Caduet
From Wikipedia, the free encyclopedia
 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (July 2008) |
 |
|
 |
|
| Combination of | |
|---|---|
| Amlodipine | Calcium channel blocker |
| Atorvastatin | Statin |
| Identifiers | |
| CAS number | ? |
| ATC code | C10BX03 |
| PubChem | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
X(US) |
| Legal status | |
| Routes | Oral
|
Caduet is a medication approved by the US FDA for the treatment of high cholesterol and high blood pressure. It is a fixed dose combination drug containing amlodipine, a calcium channel blocker (commonly sold as Norvasc), and atorvastatin (Lipitor). In many other countries, the combination is sold as Envacar. It is currently being marketed by the pharmaceutical company Pfizer.
[edit] References
- "CADUET (amlodipine besylate/atorvastatin calcium) Tablets" (PDF). NDA 21-540/S-009. United States Food and Drug Administration. December 2006. http://www.fda.gov/cder/foi/label/2007/021540s009lbl.pdf. Retrieved 2008-07-06.
[edit] External links
- Manufacturer's site (caduet.com)
 |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
